BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1060 related articles for article (PubMed ID: 11286301)

  • 1. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
    Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic imaging using SPECT.
    Taki J; Matsunari I
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S34-48. PubMed ID: 17479263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
    Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging of myocardial perfusion and metabolism with positron emission tomography].
    Ishida Y; Fukuchi K; Oka M; Sagoh M; Miyake Y; Hasimoto N
    Nihon Rinsho; 1998 Mar; 56(3):813-23. PubMed ID: 9549377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography (PET): a useful tool for the assessment of cardiac metabolism].
    Alexánderson E; Gómez-Martín D; Benito I; Ruíz-Ramírez L; Ricalde A; Meave A
    Arch Cardiol Mex; 2004; 74(3):220-8. PubMed ID: 15559875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of functional recovery after revascularization in coronary artery disease using (18)F-FDG and (123)I-BMIPP SPECT.
    Sato H; Iwasaki T; Toyama T; Kaneko Y; Inoue T; Endo K; Nagai R
    Chest; 2000 Jan; 117(1):65-72. PubMed ID: 10631201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial metabolism of 123I-BMIPP during low-flow ischaemia in an experimental model: comparison with myocardial blood flow and 18F-FDG.
    Hosokawa R; Nohara R; Fujibayashi Y; Hirai T; Fujita M; Magata Y; Tadamura E; Konishi J; Sasayama S
    Eur J Nucl Med; 2001 Nov; 28(11):1630-9. PubMed ID: 11702104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical roles of perfusion and metabolic imaging.
    Tamaki N; Kuge Y; Tsukamoto E
    J Cardiol; 2001; 37 Suppl 1():57-64. PubMed ID: 11433829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging myocardial metabolism.
    Yoshinaga K; Tamaki N
    Curr Opin Biotechnol; 2007 Feb; 18(1):52-9. PubMed ID: 17157495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial imaging using PET and SPECT].
    Tamaki N; Morita K
    Nihon Rinsho; 1998 Oct; 56(10):2550-5. PubMed ID: 9796318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.
    Syrota A; Jehenson P
    Eur J Nucl Med; 1991; 18(11):897-923. PubMed ID: 1661237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
    Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
    J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium.
    Tsubokawa A; Lee JD; Shimizu H; Nakano A; Uzui H; Takeuchi M; Tsuchida T; Yonekura Y; Ishii Y; Ueda T
    J Nucl Med; 1997 Dec; 38(12):1835-7. PubMed ID: 9430454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.